Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Merck

Is Merck Stock Outperforming the Dow?

As Merck has outperformed the Dow recently, analysts remain moderately optimistic about the stock’s prospects.

Stock Market Today: Dow, Nasdaq Firm As Trump Teases Putin Move; This New Warren Buffett Stock Rallies Again (Live Coverage)

Stock Market Today: Dow, Nasdaq Firm As Trump Teases Putin Move; This New Warren Buffett Stock Rallies Again (Live Coverage)

The Dow Jones fell and Nasdaq edged up. A new Warren Buffett equity rose on the stock market today. President Donald Trump teased a Putin move. Solar stocks shined.

Investors Business Daily

Merck, Pfizer-Backed Therapy Improves Outcomes For Cisplatin-Ineligible Bladder Cancer Patients

Merck, Pfizer-Backed Therapy Improves Outcomes For Cisplatin-Ineligible Bladder Cancer Patients

On Tuesday, Merck Co. Inc. (NYSE:MRK) released topline results from the Phase 3 KEYNOTE-905 trial (also known as EV-303) in patients with muscle-invasive bladder cancer (MIBC) who are ineligible for cisplatin-based chemotherapy.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

RFK Jr.'s vow to overhaul vaccine injury program echoes grievances of anti-vaccine movement

Health Secretary Robert F

The Independent UK

Is Wall Street Bullish or Bearish on Merck Stock?

Despite Merck’s underperformance relative to the broader market over the past year, analysts continue to maintain fair confidence regarding its future potential.

This Blue-Chip Dividend Stock Is Stuck in the Tariff Crosshairs. Can Cost Cuts Save the Day?

Merck faces intense pressure from new global tariffs and a looming Keytruda patent expiration, but is fighting back with a $3 billion cost-cutting plan and a $10 billion push into new therapies —moves that analysts say could revive the shares if executed well.

1 Blue-Chip Dividend Stock That Still Has Room to Run

This pharmaceutical leaders offers a combination of growth, income, and innovation.

inkl

Read news from The Economist, FT, and more,
with one subscription

AI Stock With Unique Focus Pulls Off This Trifecta With Palantir, Nvidia

AI Stock With Unique Focus Pulls Off This Trifecta With Palantir, Nvidia

As top funds bet big on AI stocks Nvidia and Palantir, they also scooped up Veeva stock as it teases a breakout.

Investors Business Daily

Merck CEO Sees Minimal EU Tariffs Impact, Warns Of Gardasil Challenges

Merck CEO Sees Minimal EU Tariffs Impact, Warns Of Gardasil Challenges

Merck Co. Inc. (NYSE:MRK) shares fell over 6% in early trading Tuesday after the pharmaceutical giant reported a mixed second-quarter earnings picture, with adjusted earnings surpassing analyst consensus but overall sales experiencing a slight year-over-year decline and missing revenue expectations.

Merck Stock Falls After Layoff Announcement, Gardasil Sales Drop

Merck Stock Falls After Layoff Announcement, Gardasil Sales Drop

Merck stock fell early Tuesday after Q2 results. The Dow Jones drugmaker plans for job cuts as part of restructuring initiative.

Investors Business Daily

Stock Market Today: Dow Falls 200 Points, Nasdaq Ends Win Streak; Nvidia Makes This Move (Live Coverage)

Stock Market Today: Dow Falls 200 Points, Nasdaq Ends Win Streak; Nvidia Makes This Move (Live Coverage)

The Dow Jones fared the worst of the major indexes. Meta stock moved ahead of earnings.

Investors Business Daily

After Merck, Chinese Biotech Hengrui Pharma Collaborates With GSK In Worth $12 Billion Pact

After Merck, Chinese Biotech Hengrui Pharma Collaborates With GSK In Worth $12 Billion Pact

Chinese biotech company Hengrui Pharma partnered with GSK plc (NYSE:GSK) on Monday to develop up to 12 medicines.

How To Earn $500 A Month From Merck Stock Ahead Of Q2 Earnings

How To Earn $500 A Month From Merck Stock Ahead Of Q2 Earnings

Merck Co., Inc. (NYSE:MRK) will release earnings results for the second quarter before the opening bell on Tuesday, July 29.

Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pills

Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pills

Imagine this: a hospital conference room, lights low, filled with decision-makers. A sales representative clicks through slides driven by Palantir Technologies’ (NASDAQ:PLTR) Foundry platform, highlighting real-time data integration and pinpoint analytics that would make Pharma RD from the past look like it’s still sending lab results by fax. Down the…

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Veeva Systems Breaks Up With Salesforce, Then Woos Merck

This software stock is nearing the buy point of a newly formed flat base. Here's how Merck is expanding its long-term partnership with Veeva Systems.

Stocks Settle Higher on Tech Stock Strength and Lower Bond Yields

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed up +0.61%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.72%. September E-mini S&P futures (ESU25 ) are up +0.57%, and September E-mini Nasdaq futures...

Stocks Climb on Strength in the Magnificent Seven Stocks

The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.28%. September E-mini S&P futures (ESU25 ) are up +0.22%, and September E-mini Nasdaq futures...

What You Need To Know Ahead of Merck's Earnings Release

Merck is set to announce its second-quarter results later this month, and analysts anticipate double-digit earnings dip.

Get all your
news in one place.

100’s of premium titles.
One news app.

Stocks See Support as Investors Await Tariff News

The S&P 500 Index ($SPX ) (SPY ) today is up +0.66%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.83%. September E-mini S&P futures (ESU25 ) are up +0.56%, and September E-mini Nasdaq futures...

Investors Business Daily

Merck Plots $10 Billion Takeover Of COPD Drugmaker Verona Pharma

Merck said Wednesday it would buy COPD drugmaker Verona Pharma for $10 billion. The news sent Verona stock flying.

Investors Business Daily

Stock Market Today: Dow Rises, Nasdaq At Record High As Nvidia Hits $4 Trillion Mark

The Dow Jones average finished higher Wednesday after the Fed's June minutes flicked to potential rate cuts. Nvidia set a new high, and hit the $4 trillion mark in valuation.

RFK Jr. Overhauls CDC Vaccine Panel, Sparking Expert Backlash, Boycott From Top Medical Group

Health Secretary Robert F. Kennedy Jr.'s newly reconstituted vaccine advisory panel is facing criticism from medical experts and former federal officials after its first meeting strayed sharply from established scientific review norms.

The Guardian - US

First meeting of new CDC vaccine panel reveals policy chaos sown by RFK Jr

Health secretary unilaterally appointed ACIP’s eight new members, several of whom are critical of immunizations

Merck exec says Chernobyl changed the course of her life after her father begged her to leave nuclear physics on his deathbed

Gen Z grads are slamming degrees as worthless—but Fortune 500 boss, Doina Ionescu, says her MBA was the best investment because ‘it has fundamentally changed me as a person’.

Could the answers to cancer lie in space? Why off-Earth research is heating up

The space environment is not kind to human bodies. The final frontier may therefore be the perfect place to study cancer — and someday even treat it.

People

136,036 stories

Robert F. Kennedy Jr

Martin Kulldorff

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

298,465 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play